A detailed history of Ensign Peak Advisors, Inc transactions in Lantheus Holdings, Inc. stock. As of the latest transaction made, Ensign Peak Advisors, Inc holds 34,147 shares of LNTH stock, worth $2.95 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
34,147
Previous 24,002 42.27%
Holding current value
$2.95 Million
Previous $1.93 Million 94.45%
% of portfolio
0.01%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$77.7 - $123.62 $788,266 - $1.25 Million
10,145 Added 42.27%
34,147 $3.75 Million
Q2 2024

Aug 13, 2024

SELL
$58.87 - $83.05 $1.42 Million - $2.01 Million
-24,170 Reduced 50.17%
24,002 $1.93 Million
Q1 2024

May 14, 2024

SELL
$51.07 - $68.26 $401,818 - $537,069
-7,868 Reduced 14.04%
48,172 $3 Million
Q4 2023

Feb 14, 2024

BUY
$55.6 - $77.89 $58,268 - $81,628
1,048 Added 1.91%
56,040 $3.47 Million
Q3 2023

Nov 13, 2023

SELL
$60.27 - $90.75 $281,340 - $423,621
-4,668 Reduced 7.82%
54,992 $3.82 Million
Q2 2023

Aug 14, 2023

BUY
$82.41 - $99.65 $2.8 Million - $3.39 Million
33,980 Added 132.32%
59,660 $5.01 Million
Q1 2023

May 15, 2023

BUY
$47.76 - $82.86 $164,294 - $285,038
3,440 Added 15.47%
25,680 $2.12 Million
Q4 2022

Feb 13, 2023

BUY
$48.76 - $77.67 $112,148 - $178,641
2,300 Added 11.53%
22,240 $1.13 Million
Q3 2022

Nov 14, 2022

SELL
$61.42 - $86.29 $432,396 - $607,481
-7,040 Reduced 26.09%
19,940 $1.4 Million
Q4 2021

Feb 11, 2022

SELL
$22.54 - $30.44 $311,502 - $420,680
-13,820 Reduced 33.87%
26,980 $779,000
Q3 2021

Nov 12, 2021

BUY
$24.23 - $28.59 $109,035 - $128,655
4,500 Added 12.4%
40,800 $1.05 Million
Q4 2019

Feb 14, 2020

BUY
$18.47 - $24.03 $670,461 - $872,289
36,300 New
36,300 $745,000

Others Institutions Holding LNTH

About Lantheus Holdings, Inc.


  • Ticker LNTH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 68,741,904
  • Market Cap $5.94B
  • Description
  • Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...
More about LNTH
Track This Portfolio

Track Ensign Peak Advisors, Inc Portfolio

Follow Ensign Peak Advisors, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ensign Peak Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ensign Peak Advisors, Inc with notifications on news.